Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.150
+0.020 (0.94%)
At close: May 1, 2026, 4:00 PM EDT
2.148
-0.002 (-0.11%)
After-hours: May 1, 2026, 7:59 PM EDT
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $739.55 million as of May 1, 2026. Its market cap has increased by 143.14% in one year.
Market Cap
739.55M
Enterprise Value
572.60M
1-Year Change
143.14%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $739.55M, a decrease of -74.33%. That is a compound annual growth rate of -16.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 739.55M | 140.21% |
| Dec 31, 2025 | 307.88M | -31.06% |
| Dec 31, 2024 | 446.60M | -17.32% |
| Dec 29, 2023 | 540.17M | -40.45% |
| Dec 30, 2022 | 907.08M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SpyGlass Pharma | 799.56M |
| Kura Oncology | 778.45M |
| First Tracks Biotherapeutics | 777.68M |
| Absci | 764.80M |
| Tenax Therapeutics | 752.46M |
| Alpha Tau Medical | 751.60M |
| Vor Biopharma | 750.47M |
| Gyre Therapeutics | 712.25M |